Scientific journal
Научное обозрение. Медицинские науки
ISSN 2500-0780
ПИ №ФС77-57452

Personal portfolio

PATHOGENETIC JUSTIFICATION OF USE OF ETHYLMETHYLHYDROXIPYRIDINE SUCCINATE AT THE MALE INFERTILITY, CAUSED BY THE CHRONIC BACTERIAL PROSTATITIS

Belyi L.E. 1 Konshin I.I. 1 Soloviev D.A. 1
1 Ulyanovsk state University
Research objective – studying of efficiency of application ethylmethylhydroxipyridin succinate for male infertility correction at patients with a chronic bacterial prostatitis. For confirmation of existence of a chronic bacterial prostatitis carried out microscopical research of a secret of a prostate and bacteriological research ejaculate. Results of a spermogram were interpreted in compliance by standard values of indicators of an ejaculate recommended WHO in the 5th edition of 2010. Patients with a chronic bacterial prostatitis were divided into 3 groups - the first group included 20 patients with the chronic bacterial prostatitis, being accompanied the male infertility, receiving during 4 weeks the standard conservative therapy including antibiotics, a - adrenoblockers, nonsteroid antiinflammatory preparations, bioregulatory peptides, immunomodulators, and on its termination the medicinal therapy referred on nonspecific stimulation of a spermatogenesis. The second group was made by 13 patients who during traditional therapy within 4 weeks received ethylmethylhydroxipyridine succinate (125 mg/days). The third group was made by 18 patients who during traditional therapy and nonspecific stimulation of a spermatogenesis (the general duration of therapy of 58 days) received ethylmethylhydroxipyridine succinate (125 mg/days). It is proved that application ethylmethylhydroxipyridine succinate for correction of the patospermia caused by a chronic bacterial prostatitis, is pathogenetically proved and it is expedient. It is established that the optimum decision is consecutive including ethylmethylhydroxipyridine succinate in structure of traditional complex therapy of a chronic bacterial prostatitis, and the subsequent schemes of medicinal stimulation of a spermatogenesis.